Related Experiment Video
Updated: Jun 29, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Quality indicators for depression care in HIV patients
Jeffrey M Pyne1, Steven M Asch, Katherine Lincourt
1CAVHS, Center for Mental Health Outcomes Research, North Little Rock, USA. jmpyne@uams.edu
AIDS Care
|October 1, 2008
Summary
A new set of quality indicators for depression in Human Immunodeficiency Virus (HIV) patients has been developed. These indicators aim to improve the quality of care for HIV depression, addressing key areas like screening and treatment optimization.
Area of Science:
- Medical Research
- Public Health
- Clinical Practice
Background:
- Patients with Human Immunodeficiency Virus (HIV) exhibit a higher risk of developing depression.
- A standardized set of quality indicators for managing depression in HIV-positive individuals is currently lacking.
- This gap necessitates the development of specific tools to measure and enhance care quality.
Purpose of the Study:
- To develop a comprehensive set of quality of care indicators for depression specifically within the context of HIV.
- To provide an evidence-based framework for assessing and improving depression management in HIV patients.
Main Methods:
- Systematic literature review on depression and HIV-related depression.
- Convening a modified Delphi expert panel comprising HIV physicians, psychiatrists, and a pharmacist.
- Evaluating 80 candidate quality indicators for validity and feasibility using established criteria.
Main Results:
- Seventy-four percent of candidate indicators met main analysis criteria for validity and feasibility.
- Sixty-one percent met sensitivity analysis criteria.
- Key approved indicators include depression screening frequency, integrated care for hepatitis C co-infection, optimizing treatment with cognitive impairment, and adjusted antidepressant dosing.
Conclusions:
- The developed quality indicators offer a valuable framework for measuring and guiding the quality of depression care in HIV patients.
- These indicators address specific challenges in HIV-depression management, including co-morbidities and treatment complexities.
- Implementation of these indicators can lead to improved patient outcomes and more effective care strategies.
Related Concept Videos
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:27Depressive Disorders: MDD and Dysthymia
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
01:03Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Calcium Ion Concentration Mechanism
If over time, all...
01:05Long-term Depression
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.